Levels of LC3 resulted in being significantly increased in DLB and FTD frontal cortex specimens compared to those in CTRL specimens, showing a similar trend in the temporal, frontal, and occipital cortex of AD specimens. The gene discussed is MAP1LC3A; the disease is Alzheimer disease.